Core Laboratories N.V. (CLB) Misses Q3 EPS by 9c; Guides Q4 EPS, Revs

Go back to Core Laboratories N.V. (CLB) Misses Q3 EPS by 9c; Guides Q4 EPS, Revs

HSBC Upgrades Core Laboratories (CLB) to Overweight

October 19, 2012 1:17 PM EDT

HSBC upgraded Core Laboratories (NYSE: CLB) from Neutral to Overweight with a price target of $128.00 (from $129.00).

For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on... More